We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Tripos Discovery Research Enters Agreement with CombinatoRx to Optimize Novel Compounds

News   Aug 29, 2007

 
Tripos Discovery Research Enters Agreement with CombinatoRx to Optimize Novel Compounds
 
 
 

RELATED ARTICLES

Study Suggests a Lack of Racial Diversity in Cancer Drug Trials

News

A new study has found that fewer than 8% of cancer drug trials reported participation from the four major races in the United States – white, Asian, black and Hispanic – between 2008 and 2018.

READ MORE

Grant Fuels Drug Discovery Efforts for ALS

News

Scientists have received a $3.1 million grant to collaborate and investigate drug therapies for amyotrophic lateral sclerosis (ALS).

READ MORE

Ebola Patients Have a 90% Survival Rate After Injection With New Drugs

News

Two Ebola drugs have proven so effective in a clinical trial that researchers will make the treatments available to anyone infected with the virus in the Democratic Republic of the Congo, where Ebola has killed nearly 1,900 people over the past year.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE